BNP Paribas Financial Markets’s Orgenesis Inc. Common Stock ORGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7
| Closed | -$31 | – | 5587 |
|
|
2024
Q3 | $31 | Sell |
7
-1
| -13% | -$7 | ﹤0.01% | 4097 |
|
|
2024
Q2 | $45 | Hold |
8
| – | – | ﹤0.01% | 3991 |
|
|
2024
Q1 | $62 | Hold |
8
| – | – | ﹤0.01% | 3981 |
|
|
2023
Q4 | $38 | Hold |
8
| – | – | ﹤0.01% | 3971 |
|
|
2023
Q3 | $46 | Hold |
8
| – | – | ﹤0.01% | 3871 |
|
|
2023
Q2 | $104 | Hold |
8
| – | – | ﹤0.01% | 3858 |
|
|
2023
Q1 | $88 | Hold |
8
| – | – | ﹤0.01% | 3782 |
|
|
2022
Q4 | $146 | Hold |
8
| – | – | ﹤0.01% | 3937 |
|
|
2022
Q3 | $106 | Hold |
8
| – | – | ﹤0.01% | 4642 |
|
|
2022
Q2 | $182 | Sell |
8
-1
| -11% | -$28 | ﹤0.01% | 3999 |
|
|
2022
Q1 | $309 | Sell |
9
-28
| -76% | -$851 | ﹤0.01% | 4061 |
|
|
2021
Q4 | $1.07K | Sell |
37
-5
| -12% | -$196 | ﹤0.01% | 4051 |
|
|
2021
Q3 | $2.07K | Sell |
42
-270
| -87% | -$13.6K | ﹤0.01% | 3797 |
|
|
2021
Q2 | $15.8K | Sell |
312
-338
| -52% | -$17K | ﹤0.01% | 3604 |
|
|
2021
Q1 | $37.3K | Buy |
650
+343
| +112% | +$22.3K | ﹤0.01% | 3674 |
|
|
2020
Q4 | $13.8K | Sell |
307
-69
| -18% | -$3.32K | ﹤0.01% | 3897 |
|
|
2020
Q3 | $18.9K | Buy |
376
+308
| +453% | +$16.7K | ﹤0.01% | 3847 |
|
|
2020
Q2 | $4.12K | Buy |
+68
| New | +$4.11K | ﹤0.01% | 4071 |
|
BNP Paribas Financial Markets's ORGS Position: Q4 2024 in Review
BNP Paribas Financial Markets sold out of Orgenesis Inc. Common Stock (ORGS) in Q4 2024, closing a stake of 7 shares — an estimated $31 sold.
BNP Paribas Financial Markets first reported a position in ORGS in Q2 2020 and held it in 18 quarters. The position peaked at $37.3K in Q1 2021. 0 funds tracked by Wall St. Rank hold ORGS as of Q4 2024.
- BNP Paribas Financial Markets reported no remaining Orgenesis Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- BNP Paribas Financial Markets sold 7 Orgenesis Inc. Common Stock shares in Q4 2024, an estimated $31.
- BNP Paribas Financial Markets first reported a position in Orgenesis Inc. Common Stock in Q2 2020 and held it in 18 quarters.
- BNP Paribas Financial Markets's Orgenesis Inc. Common Stock position peaked at $37.3K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q4 2024.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2024, filed 14 Feb 2025.